Posted On: 09/17/2014 5:19:21 PM
Post# of 30034
Fibonacci has lost it, totally! So has watsonhelper. They are both phonies. The 12 week validation study being conducted by ICON will be completed early December. We don't have to wait after that to commercialize, we can do it immediately.
Perhaps he is suggesting that we might not get the multivariant results for a few weeks after that. Maybe, but that won't stop our progress commercializing.
Besides, multivariant data is not as important as we used to think. We used to think that Big Pharma doing thousands of tests during clinical trails were willing to test all 6 univariant bio-markets and do the math necessary to get multivariant scores in the 90s. They aren't that excited about that. They are according to Gerald very pleased with the ease of Lympro univariant CD 19 and it's 80% accuracy on a stand alone basis! And it's cheapness!
Fibonacci is just bashing.
Perhaps he is suggesting that we might not get the multivariant results for a few weeks after that. Maybe, but that won't stop our progress commercializing.
Besides, multivariant data is not as important as we used to think. We used to think that Big Pharma doing thousands of tests during clinical trails were willing to test all 6 univariant bio-markets and do the math necessary to get multivariant scores in the 90s. They aren't that excited about that. They are according to Gerald very pleased with the ease of Lympro univariant CD 19 and it's 80% accuracy on a stand alone basis! And it's cheapness!
Fibonacci is just bashing.
(0)
(0)Scroll down for more posts ▼
